http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0047224-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_273e6d06c1fea5152fd990bfebe93e11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46de370f896189cbed72c49e911418d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b0142c4f78de041747e35c36c2e7c2c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
filingDate 2000-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_813a9addaae908edacdc964cc1164568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9fe2317d0454455af300b3bba6b6b1c
publicationDate 2000-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0047224-A3
titleOfInvention Vaccine formulation comprising monoglycerides or fatty acids as adjuvant
abstract A vaccine formulation against a microorganism is disclosed. The formulation comprises: as adjuvant, one or more substances selected from a) monoglyceride preparations having at least 80 % monoglyceride content and b) fatty acids of the general formula CH3-(CH2)n-COOH where 'n' may be varied between 4 and 22, and where the acyl chain may contain one or more unsaturated bonds, and as immunizing component, an immunogenic product consisting of antigenically active carbohydrate moieties (ACM) derived from said microorganism which are each covalently coupled, possibly via identical divalent bridge groups, to immunologically active carriers (IAC). The vaccine formulation is e.g. against Mycobacterium tuberculosis and in that case the formulation may comprise, as adjuvant, a mixture of mono-olein and oleic acid, and possibly soybean oil, and, as immunizing component, lipoarabinomamman-tetanus toxoid (LAM-TT).
priorityDate 1999-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0448126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9747320-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9735613-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420229795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13296868
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407124392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393971
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393970

Total number of triples: 38.